Literature DB >> 1640863

Effect of a moderate alcohol intake on the lipoproteins of normotriglyceridemic obese subjects compared with normoponderal controls.

M Hagiage1, C Marti, D Rigaud, C Senault, F Fumeron, M Apfelbaum, A Girard-Globa.   

Abstract

Moderate alcohol intake is frequently associated with an elevated concentration of high-density lipoprotein (HDL), which is one of the potential causes for the relative decrease in cardiovascular risk reported in moderate drinkers. Conversely, low HDL concentrations, particularly HDL2, in obese subjects may be a risk factor. The effect of 30 g alcohol daily (wine) during 14 days following a period of abstinence was studied in seven normolipidemic obese subjects (body mass index [BMI], 30 +/- 1.7 kg/m2) compared with seven normoponderal controls (BMI, 22 +/- 1.2 kg/m2). Alcohol caused apolipoprotein (apo) AI and apo AII concentrations to increase in all controls by 12% and 16% (P less than .05), but not in obese subjects. Lipoprotein (Lp) AI HDL particles (without AII) were initially in the same proportions in the two groups. Their increase in controls only (P less than .03) was not matched by an increase in HDL2 in all subjects. In obese subjects, neither Lp AI nor HDL2 were increased by alcohol, but their HDL-triglyceride (TG) contents, initially elevated, were normalized. Cholesterol ester (CE) transfer activity was not different in controls and obese subjects during abstinence (105.7 +/- 40.8 v 104.8 +/- 34.5 mmol/mg protein/h). It was notably depressed by alcohol in controls (74.2 +/- 27.4, P less than .002), but not in obese subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640863     DOI: 10.1016/0026-0495(92)90167-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction.

Authors:  F Fumeron; D Betoulle; G Luc; I Behague; S Ricard; O Poirier; R Jemaa; A Evans; D Arveiler; P Marques-Vidal
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

2.  Moderate alcohol consumption and atherosclerosis : Meta-analysis of effects on lipids and inflammation.

Authors:  Yunying Huang; Yongmei Li; Sichao Zheng; Xin Yang; Tenghua Wang; Jie Zeng
Journal:  Wien Klin Wochenschr       Date:  2017-07-31       Impact factor: 1.704

Review 3.  Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies.

Authors:  Susan E Brien; Paul E Ronksley; Barbara J Turner; Kenneth J Mukamal; William A Ghali
Journal:  BMJ       Date:  2011-02-22

4.  Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies.

Authors:  Trine L Wilkens; Kaare Tranæs; Jane N Eriksen; Lars O Dragsted
Journal:  Nutr Rev       Date:  2022-04-08       Impact factor: 6.846

5.  Short-term red wine consumption promotes differential effects on plasma levels of high-density lipoprotein cholesterol, sympathetic activity, and endothelial function in hypercholesterolemic, hypertensive, and healthy subjects.

Authors:  Ana C M Andrade; Fernando H Y Cesena; Fernanda M Consolim-Colombo; Silmara R Coimbra; Alexandre M Benjó; Eduardo M Krieger; Protasio Lemos da Luz
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

Review 6.  Focus on: The cardiovascular system: what did we learn from the French (Paradox)?

Authors:  Daria Mochly-Rosen; Samir Zakhari
Journal:  Alcohol Res Health       Date:  2010

Review 7.  Modification of High-Density Lipoprotein Functions by Diet and Other Lifestyle Changes: A Systematic Review of Randomized Controlled Trials.

Authors:  Albert Sanllorente; Camille Lassale; Maria Trinidad Soria-Florido; Olga Castañer; Montserrat Fitó; Álvaro Hernáez
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.